RT Journal Article
SR Electronic
T1 Chromosome X-Wide Common Variant Association Study (XWAS) in Autism Spectrum Disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.18.24310640
DO 10.1101/2024.07.18.24310640
A1 Mendes, Marla
A1 Chen, Desmond Zeya
A1 Engchuan, Worrawat
A1 Leal, Thiago Peixoto
A1 Thiruvahindrapuram, Bhooma
A1 Trost, Brett
A1 Howe, Jennifer L.
A1 Pellecchia, Giovanna
A1 Nalpathamkalam, Thomas
A1 Alexandrova, Roumiana
A1 Salazar, Nelson Bautista
A1 McKee, Ethan Alexander
A1 Alfaro, Natalia Rivera
A1 Lai, Meng-Chuan
A1 Bandres-Ciga, Sara
A1 Roshandel, Delnaz
A1 Bradley, Clarrisa A.
A1 Anagnostou, Evdokia
A1 Sun, Lei
A1 Scherer, Stephen W.
YR 2024
UL http://medrxiv.org/content/early/2024/07/18/2024.07.18.24310640.abstract
AB Autism Spectrum Disorder (ASD) displays a notable male bias in prevalence. Research into rare (<0.1) genetic variants on the X chromosome has implicated over 20 genes in ASD pathogenesis, such as MECP2, DDX3X, and DMD. The "female protective effect" in ASD suggests that females may require a higher genetic burden to manifest similar symptoms as males, yet the mechanisms remain unclear. Despite technological advances in genomics, the complexity of the biological nature of sex chromosomes leave them underrepresented in genome-wide studies. Here, we conducted an X chromosome-wide association study (XWAS) using whole-genome sequencing data from 6,873 individuals with ASD (82% males) across Autism Speaks MSSNG, Simons Simplex Cohort SSC, and Simons Foundation Powering Autism Research SPARK, alongside 8,981 population controls (43% males). We analyzed 418,652 X-chromosome variants, identifying 59 associated with ASD (p-values 7.9×10⁻⁶ to 1.51×10⁻⁵), surpassing Bonferroni-corrected thresholds. Key findings include significant regions on chrXp22.2 (lead SNP=rs12687599, p=3.57×10⁻⁷) harboring ASB9/ASB11, and another encompassing DDX53/PTCHD1-AS long non-coding RNA (lead SNP=rs5926125, p=9.47×10⁻⁶). When mapping genes within 10kb of the 59 most significantly associated SNPs, 91 genes were found, 17 of which yielded association with ASD (GRPR, AP1S2, DDX53, HDAC8, PCDH19, PTCHD1, PCDH11X, PTCHD1-AS, DMD, SYAP1, CNKSR2, GLRA2, OFD1, CDKL5, GPRASP2, NXF5, SH3KBP1). FGF13 emerged as a novel X-linked ASD candidate gene, highlighted by sex-specific differences in minor allele frequencies. These results reveal significant new insights into X chromosome biology in ASD, confirming and nominating genes and pathways for further investigation.Competing Interest StatementAt the time of this study and its publication, S.W.S. served on the Scientific Advisory Committee of Population Bio. Intellectual property from aspects of his research held at The Hospital for Sick Children are licensed to Athena Diagnostics and Population Bio. These relationships did not influence data interpretation or presentation during this study but are disclosed for potential future considerations. Funding StatementThis study was funded by CGEn HostSeq/CIHR fellowship (CGE 185054),SickKids Restracomp Fellowship, the Intramural Research Program of the NIH and the National Institute on Aging (NIA), Canadian Institutes of Health Research Sex and Gender Science Chair (GSB 171373) and the Northbridge Chair in Pediatric Research at The Hospital for Sick Children and the University of Toronto.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Board (Ethics committee) of The Hospital for Sick Children gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://research.mss.ng/ https://base.sfari.org https://www.internationalgenome.org https://www.cgen.ca/hostseq-databank-access-request MGRB genomic data is deposited at the European Genome-Phenome Archive under study ID EGAS00001003511 https://research.mss.ng/ https://base.sfari.org https://www.internationalgenome.org https://www.cgen.ca/hostseq-databank-access-request